
The first RSV vaccine designed to protect infants is under consideration by a panel of advisers to the U.S. Food and Drug Administration. An independent committee of experts will vote Thursday on whether to recommend the shot for pregnant mothers at 24 to 36 weeks gestation. “Before the pandemic, RSV was the No. 1 cause… read on > read on >